Resultats globals: 1 registres trobats en 0.01 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
12 p, 648.4 KB Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome / Bittner, Vera A. (University of Alabama at Birmingham) ; Szarek, Michael (State University of New York) ; Aylward, Philip (South Australian Health and Medical Research Institute) ; Bhatt, Deepak L. (Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School) ; Díaz, Rafaël J. (Instituto Cardiovascular de Rosario) ; Edelberg, Jay M. (Sanofi) ; Fras, Zlatko (Univerza V Ljubljani) ; Goodman, Shaun G. (University of Toronto) ; Halvorsen, Sigrun (University of Oslo) ; Hanotin, Corinne (Sanofi) ; Harrington, Robert A. (Stanford University) ; Jukema, J. Wouter (Leiden University Medical Center) ; Loizeau, Virginie (Sanofi) ; Moriarty, Patrick Maurice (University of Kansas Medical Center) ; Moryusef, Angèle (Sanofi) ; Pordy, Robert (Regeneron Pharmaceuticals Inc.) ; Roe, Matthew T. (Duke University School of Medicine) ; Sinnaeve, Peter (University of Leuven) ; Tsimikas, Sotirios (University of California San Diego) ; Vogel, Robert A. (University of Colorado School of Medicine) ; White, Harvey D. (Green Lane Cardiovascular Services Auckland City Hospital) ; Zahger, Doron (Soroka University Medical Center) ; Zeiher, Andreas Michael (Goethe University) ; Steg, Philippe Gabriel (Royal Brompton Hospital (Londres)) ; Schwartz, Gregory G. (University of Colorado School of Medicine) ; Matas Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ; Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Coca Payeras, Antonio (Hospital Clínic i Provincial de Barcelona) ; Cequier, Ángel (Hospital Universitari de Bellvitge) ; García-Dorado, David (Hospital Universitari Vall d'Hebron) ; Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ; Universitat Autònoma de Barcelona
Lipoprotein(a) concentration is associated with cardiovascular events. Alirocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, lowers lipoprotein(a) and low-density lipoprotein cholesterol (LDL-C). [...]
2020 - 10.1016/j.jacc.2019.10.057
Journal of the American College of Cardiology, Vol. 75 Núm. 2 (21 2020) , p. 133-144  

Vegeu també: autors amb noms similars
1 Sinnaeve, P.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.